Scope Firms, FDA Faulted In 300-Page Senate Report Seeking Device Reforms
This article was originally published in The Gray Sheet
Senate HELP Ranking Member Sen. Patty Murray in a staff report criticizes FDA and manufacturers for reacting slowly to duodenoscope contamination incidents in 2013. The report says FDA needs a more robust device surveillance system and calls for more attention to 510(k) modification policies. Murray is a key partner in ongoing Senate work to produce a so-called "medical innovation" bill.
You may also be interested in...
Olympus, Pentax Working On Responses To Sen. Murray Duodenoscope Contamination Concerns
Two duodenoscope manufacturers – Olympus and Pentax – this week joined Fujifilm in saying they are aware of Senate HELP Committee ranking member Patty Murray’s concerns about recently released duodenoscope contamination levels and are working to complete postmarket surveillance studies of their devices, as required by the US FDA.
US Senators Press Agency Witnesses On Adding UDIs To Claims Forms
Democratic Sens. Patty Murray and Elizabeth Warren pressed US CMS and HHS officials at a recent hearing on making certain a line is added to Medicare claims forms for unique device identifiers, both to reduce Medicare costs and improve patient safety.
Industry Urges Caution In Response To Growing Push For 'Real-World' Device Evaluation System
AdvaMed's new chief Scott Whitaker says industry doesn't want to sign onto a new "national evaluation system" for devices championed by FDA until it is convinced that the initiative will enhance, rather than hinder, premarket product development.